New study aims to unlock the mystery of persistent breathlessness in COPD

NCT ID NCT07160322

Recruiting now Knowledge-focused Sponsor: Seoul National University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 730 adults with COPD who still have severe shortness of breath even after using standard inhalers. Researchers will track their health over time to see what factors lead to more flare-ups, faster lung decline, or death. The goal is to better understand this difficult condition and guide future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which COPD patients are at highest risk for flare-ups or decline, leading to better personalized care.
What could go wrong: This is an observational study, not testing a new treatment. It cannot prove cause and effect, and results may not apply to all COPD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset Dyspnea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD

Contacts and locations

Locations

Seoul National University College of Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center
RECRUITING

Seoul, Seoul, 07061, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.